WallStreetZenWallStreetZen

NASDAQ: FRTX
Fresh Tracks Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their FRTX stock forecasts and price targets.

Forecast return on equity

Is FRTX forecast to generate an efficient return?
Company
N/A
Industry
0.9%
Market
28.66%

Forecast return on assets

Is FRTX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.08%

FRTX revenue growth forecast

How is FRTX forecast to perform vs Biotechnology companies and vs the US market?
Company
77.7%
Industry
35.79%
Market
8.17%
FRTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FRTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FRTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FRTX$0.90N/AN/A
XTLB$0.97N/AN/A
CNSP$1.27N/AN/A
BLPH$0.44$18.50+4,123.74%Strong Buy
WINT$1.00N/AN/A

Fresh Tracks Therapeutics Stock Forecast FAQ

What is FRTX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: FRTX) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Fresh Tracks Therapeutics stock.

What is FRTX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: FRTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.08%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.